Skip to main content
. 2020 Jan 21;2020:7025738. doi: 10.1155/2020/7025738

Table 4.

Results of Cox regression analysis for factors associated with survival status among patients living with HIV/AIDS taking IPT and ART versus ART alone in Northern Ethiopia, 2009–2017.

Variable Survival status Death, n (%) CHR [95% CI] p value AHR [95% CI] p value
Alive, n (%)
Sex Female 1,076 (94.4) 64 (5.6) 0.465 [0.336–0.643] <0.0001∗∗ 0.691 [0.495–0.964] 0.030
Male 638 (88.2) 85 (11.8) Reference Reference Reference
Residence Urban 1,161 (93.0) 87 (7.0) 0.680 [0.491–0.941] 0.020 0.595 [0.427–0.831] 0.002
Rural 553 (89.9) 62 (10.1) Reference Reference
Scheduling Unscheduled 641 (89.0) 79 (11.0) 0.712 [0.606–0.837] 0.0001∗∗ 1.601 [1.154–2.222] 0.005
Scheduled 1,073 (93.9) 70 (6.1) Reference Reference
Baseline functional status Bedridden (2) 121 (88.3) 16 (11.7) 2.163 [1.255–3.726] 0.005 1.617 [0.935–2.796] 0.086
Ambulatory (1) 415 (86.6) 64 (13.4) 2.515 [1.790–3.534] <0.0001∗∗ 2.324 [1.643–3.288] <0.0001∗∗
Working 1,178 (94.5) 69 (5.5) Reference Reference
CD4+ T cells (in cells/mm3) ≥250 1,318 (96.1) 54 (3.9) 0.176 [0.126–0.246] <0.0001∗∗ 0.217 [0.154–0.307] <0.0001∗∗
<250 396 (80.7) 95 (19.3) Reference <0.0001∗∗ Reference
Exposure to IPT No 1113 (89.6) 129 (10.4) Reference Reference
Yes 601 (96.8) 20 (3.2) 0.296 [0.185–0.474] <0.0001∗∗ 0.339 [0.211–0.545] <0.0001∗∗

Statistically significant atp < 0.05; ∗∗∗statistically significant at p < 0.0001. The following factors were analyzed at the crude stage: sex, age, place of residence, scheduling, baseline functional status, specific ARV regimen, body mass index, exposure variable, and WHO clinical staging. AHR: adjusted hazard ratio; ARV: antiretroviral regimen; BMI: body mass index; CD4+ T cells: cluster of differentiation 4 positive T cells; CI: confidence interval; CHR: crude hazard ratio; WHO: World Health Organization.